[Ala11, D-Leu15]-Orexin B (Human)
Arg-Ser-Gly-Pro-Pro-Gly-Leu-Gln-Gly-Arg-Ala-Gln-Arg-Leu-D-Leu-Gln-Ala-Ser-Gly-Asn-His-Ala-Ala-Gly-Ile-Leu-Thr-Met-NH2
4483-s 0.1 mg | 85.00 EUR
| (M.W. 2857.3) | C120H206N44O35S | [532932-99-3] |
Synthetic Product
Purity minimum 99.0 % including Met(O) analog (≦1.0%) per HPLC (according Data Sheet)
Orexin-2 Receptor Selective Agonist
References:
- S. Asahi, S.-I. Egashira, M. Matsuda, H. Iwaasa, A. Kanatani, M. Ohkubo, M. Ihara and H. Morishima, Bioorg. Med. Chem. Lett., 13, 111 (2003). (Original; Structure-Activity Relationship & Pharmacol.)
- J. Putula, P.M. Turunen, M.H. Jäntti, M.E. Ekholm and J.P. Kukkonen, Neurosci. Lett., 494, 57 (2011). (Pharmacol.)
